SCHEMBL32688309

SCHEMBL32688309

N#Cc1c(-c2cccc(N3CCCC3)c2)cc(=O)[nH]c1S

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.43
▸ RECQL P46063 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.40
▸ OTUD7B Q6GQQ9 2/20 0.39
▸ DRD2 P14416 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ KISS1R Q969F8 3/20 0.38
▸ HTR1A P08908 2/20 0.37
▸ HTR7 P34969 2/20 0.37
▸ USP30 Q70CQ3 1/20 0.37
▸ ATM Q13315 1/20 0.36
▸ PRMT6 Q96LA8 1/20 0.36
▸ NPBWR1 P48145 1/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ KDM5B Q9UGL1 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688188 0.99 KDM4E (0.42) KDM4ERECQLTDP1ALDH1A1OTUD7B
SCHEMBL32688129 0.92 KDM4E (0.42) KDM4ERECQLTDP1ALDH1A1DRD2
SCHEMBL32688315 0.90 CHEK1 (0.45) KDM4ERECQLTDP1DRD2KISS1R
SCHEMBL32688176 0.86 USP2 (0.47) KDM4ERECQLTDP1ALDH1A1KISS1R
SCHEMBL32688170 0.84 BRD4 (0.48) KDM4ERECQLTDP1ALDH1A1MEN1
SCHEMBL32688440 0.81 GPR119 (0.44) ALDH1A1USP30MAPT
SCHEMBL32688048 0.80 BRD4 (0.38) KDM4ERECQLTDP1ALDH1A1ATM
SCHEMBL32688076 0.78 KDM4E (0.50) KDM4ERECQLTDP1ALDH1A1ATM
SCHEMBL20339404 0.77 ATM (0.58) KDM4ERECQLTDP1ALDH1A1ATM
SCHEMBL20340038 0.77 KDM4E (0.56) KDM4ERECQLTDP1ALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KDM4E 3207/4885RECQL 1365/4885TDP1 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback